Search

Aradhana Sasan

Examiner (ID: 10759, Phone: (571)272-9022 , Office: P/1615 )

Most Active Art Unit
1615
Art Unit(s)
1615
Total Applications
1310
Issued Applications
755
Pending Applications
112
Abandoned Applications
468

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19104696 [patent_doc_number] => 11957769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-16 [patent_title] => Polyhydroxy fullerene sunscreen active agents and compositions [patent_app_type] => utility [patent_app_number] => 17/182093 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10367 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182093 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/182093
Polyhydroxy fullerene sunscreen active agents and compositions Feb 21, 2021 Issued
Array ( [id] => 17235493 [patent_doc_number] => 11179356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-23 [patent_title] => Methods and compositions to modulate the gut microbiota and to manage weight [patent_app_type] => utility [patent_app_number] => 17/180256 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31720 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180256 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/180256
Methods and compositions to modulate the gut microbiota and to manage weight Feb 18, 2021 Issued
Array ( [id] => 19674458 [patent_doc_number] => 12186296 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-01-07 [patent_title] => Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics [patent_app_type] => utility [patent_app_number] => 17/178117 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 147 [patent_no_of_words] => 96563 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178117 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/178117
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics Feb 16, 2021 Issued
Array ( [id] => 16776433 [patent_doc_number] => 20210113510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 17/137713 [patent_app_country] => US [patent_app_date] => 2020-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15143 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137713 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/137713
Stable pharmaceutical composition and methods of using same Dec 29, 2020 Issued
Array ( [id] => 18517210 [patent_doc_number] => 11707080 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Infant formula with special lipid architecture for improving postnatal growth of infants born by Caesarean section [patent_app_type] => utility [patent_app_number] => 17/775889 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11060 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775889 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/775889
Infant formula with special lipid architecture for improving postnatal growth of infants born by Caesarean section Dec 3, 2020 Issued
Array ( [id] => 16718454 [patent_doc_number] => 20210085601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => CROMOLYN COMPOSITIONS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 17/108895 [patent_app_country] => US [patent_app_date] => 2020-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12450 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17108895 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/108895
Cromolyn compositions and methods thereof Nov 30, 2020 Issued
Array ( [id] => 16883616 [patent_doc_number] => 20210169811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => CONTROLLED-RELEASE SYSTEM OF ACTIVE PHARMACEUTICAL INGREDIENT AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 17/101706 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26857 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101706 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/101706
Controlled-release system of active pharmaceutical ingredient and preparation method therefor Nov 22, 2020 Issued
Array ( [id] => 16686856 [patent_doc_number] => 20210069331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => SCINTILLATOR NANOCRYSTAL-CONTAINING COMPOSITIONS AND METHODS FOR THEIR USE [patent_app_type] => utility [patent_app_number] => 17/099663 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33184 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099663 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/099663
Scintillator nanocrystal-containing compositions and methods for their use Nov 15, 2020 Issued
Array ( [id] => 16791588 [patent_doc_number] => 20210121405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => Methods for Formulating an API, Composite Materials, and Solid Unit Dosage Forms [patent_app_type] => utility [patent_app_number] => 17/081512 [patent_app_country] => US [patent_app_date] => 2020-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3768 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17081512 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/081512
Methods for Formulating an API, Composite Materials, and Solid Unit Dosage Forms Oct 26, 2020 Abandoned
Array ( [id] => 18003433 [patent_doc_number] => 20220362199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-17 [patent_title] => ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/771173 [patent_app_country] => US [patent_app_date] => 2020-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16122 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771173 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/771173
ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS Oct 22, 2020 Pending
Array ( [id] => 16791591 [patent_doc_number] => 20210121408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => Methods of Administering Cannabinoid to People Diagnosed With HIV [patent_app_type] => utility [patent_app_number] => 17/075656 [patent_app_country] => US [patent_app_date] => 2020-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2151 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075656 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/075656
Methods of Administering Cannabinoid to People Diagnosed With HIV Oct 19, 2020 Abandoned
Array ( [id] => 16613923 [patent_doc_number] => 20210032576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => ANTI-VIRAL CLEANING COMPOSITION, METHOD OF MAKING AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/065981 [patent_app_country] => US [patent_app_date] => 2020-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065981 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/065981
Anti-viral cleaning composition, method of making and use thereof Oct 7, 2020 Issued
Array ( [id] => 16655881 [patent_doc_number] => 20210052517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => EXTENDED RELEASE PHARMACEUTICAL FORMULATION [patent_app_type] => utility [patent_app_number] => 17/030705 [patent_app_country] => US [patent_app_date] => 2020-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030705 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/030705
Extended release pharmaceutical formulation Sep 23, 2020 Issued
Array ( [id] => 16718466 [patent_doc_number] => 20210085613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => IBUDILAST ORAL FORMULATIONS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 17/027567 [patent_app_country] => US [patent_app_date] => 2020-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21237 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17027567 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/027567
Ibudilast oral formulations and methods of using same Sep 20, 2020 Issued
Array ( [id] => 17561683 [patent_doc_number] => 20220125832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => USE OF PRUSSIAN BLUE NANOPARTICLES IN THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION, DELAY OR TREATMENT OF NEURODEGENERATIVE DISEASE [patent_app_type] => utility [patent_app_number] => 17/257076 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5137 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257076 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/257076
USE OF PRUSSIAN BLUE NANOPARTICLES IN THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION, DELAY OR TREATMENT OF NEURODEGENERATIVE DISEASE Sep 17, 2020 Abandoned
Array ( [id] => 16555638 [patent_doc_number] => 20210000786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => Taxane Particles and Their Use [patent_app_type] => utility [patent_app_number] => 17/023635 [patent_app_country] => US [patent_app_date] => 2020-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17023635 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/023635
Taxane particles and their use Sep 16, 2020 Issued
Array ( [id] => 16539271 [patent_doc_number] => 20200405684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => Taxane Particles and Their Use [patent_app_type] => utility [patent_app_number] => 17/023098 [patent_app_country] => US [patent_app_date] => 2020-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13224 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17023098 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/023098
Taxane Particles and Their Use Sep 15, 2020 Abandoned
Array ( [id] => 19853960 [patent_doc_number] => 12256765 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-25 [patent_title] => Hydrolyzed pea protein-based nutrient composition [patent_app_type] => utility [patent_app_number] => 17/021339 [patent_app_country] => US [patent_app_date] => 2020-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8681 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021339 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/021339
Hydrolyzed pea protein-based nutrient composition Sep 14, 2020 Issued
Array ( [id] => 16539262 [patent_doc_number] => 20200405675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 17/016577 [patent_app_country] => US [patent_app_date] => 2020-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15128 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016577 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/016577
Stable pharmaceutical composition and methods of using same Sep 9, 2020 Issued
Array ( [id] => 16726441 [patent_doc_number] => 20210093588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => Bis-Choline Tetrathiomolybdate for Treating Wilson Disease [patent_app_type] => utility [patent_app_number] => 16/997928 [patent_app_country] => US [patent_app_date] => 2020-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997928 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/997928
Bis-choline tetrathiomolybdate for treating Wilson Disease Aug 18, 2020 Issued
Menu